Matildo, Jasmine Claire A.
HRN: 23-50-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
CEFUROXIME 500MG (TAB)
10/30/2023
11/06/2023
PO
1 Tab
BID
G1P0 UTI; Dengue W/o Warning Signs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes